The present invention provides process for preparation of crystalline Bortezomib as its monohydrate which is designated as crystalline Form-SBand characterized by having water content ranging between 3. Based on the two control voltages, a first and a second currents are formed, from which four different combinations of currents are established. The system further includes an end-station, maintained at ground electric potential, in which a wafer holding for positioning a wafer in the path of an ion beam is disposed. The second display unit includes a touchpanel. A tire component of a predetermined circumference can be accurately formed by increasing the diameter of an annular ply fabricated by successively joining an integral number of the strips such that the edge parts of the adjacent strips overlap each other with the outermost cord in the edge part of one of the adjacent strips superposed on the outermost cord in the edge part of the other strip. The method receives a design having several sets of operations for the configurable circuits to perform in different operational cycles.